Integer Holdings Corporation Issues Statement on Tariffs
Integer Holdings (NYSE: ITGR), a contract development and manufacturing organization, has issued a statement regarding the impact of recent trade policy developments and tariffs on its business. The company expects the announced tariffs to have an immaterial impact on its 2025 results.
CEO Joseph Dziedzic stated that the company estimates a $1 to $5 million impact on full-year adjusted operating income, which accounts for currently applicable tariffs and additional tariffs announced on April 2 following a 90-day pause. This estimate includes both implemented and planned mitigation actions. Integer will release its Q1 2025 financial results on April 24, 2025.
Integer Holdings (NYSE: ITGR), un'organizzazione di sviluppo e produzione su contratto, ha rilasciato una dichiarazione riguardante l'impatto dei recenti sviluppi nella politica commerciale e delle tariffe sulla sua attività. L'azienda prevede che le tariffe annunciate avranno un impatto immateriale sui risultati del 2025.
Il CEO Joseph Dziedzic ha dichiarato che l'azienda stima un impatto di 1 a 5 milioni di dollari sul reddito operativo rettificato per l'intero anno, che tiene conto delle tariffe attualmente applicabili e delle tariffe aggiuntive annunciate il 2 aprile dopo una pausa di 90 giorni. Questa stima include sia le azioni di mitigazione già implementate che quelle pianificate. Integer pubblicherà i suoi risultati finanziari del primo trimestre del 2025 il 24 aprile 2025.
Integer Holdings (NYSE: ITGR), una organización de desarrollo y fabricación por contrato, ha emitido un comunicado sobre el impacto de los recientes desarrollos en la política comercial y los aranceles en su negocio. La empresa espera que los aranceles anunciados tengan un impacto inmaterial en sus resultados de 2025.
El CEO Joseph Dziedzic declaró que la empresa estima un impacto de 1 a 5 millones de dólares en el ingreso operativo ajustado del año completo, que considera los aranceles actualmente aplicables y los aranceles adicionales anunciados el 2 de abril tras una pausa de 90 días. Esta estimación incluye tanto las acciones de mitigación implementadas como las planificadas. Integer publicará sus resultados financieros del primer trimestre de 2025 el 24 de abril de 2025.
Integer Holdings (NYSE: ITGR), 계약 개발 및 제조 조직, 최근 무역 정책 개발 및 관세가 비즈니스에 미치는 영향에 대한 성명을 발표했습니다. 회사는 발표된 관세가 2025년 결과에 미미한 영향을 미칠 것으로 예상하고 있습니다.
CEO 조셉 제지딕은 회사가 현재 적용 가능한 관세와 90일 일시 중지 후 4월 2일에 발표된 추가 관세를 고려하여 전체 연도 조정 운영 수익에 100만 달러에서 500만 달러의 영향을 추정한다고 밝혔습니다. 이 추정치는 시행된 조치와 계획된 완화 조치를 모두 포함합니다. Integer는 2025년 4월 24일에 2025년 1분기 재무 결과를 발표할 예정입니다.
Integer Holdings (NYSE: ITGR), une organisation de développement et de fabrication sous contrat, a publié une déclaration concernant l'impact des récents développements de la politique commerciale et des tarifs sur son activité. L'entreprise s'attend à ce que les tarifs annoncés aient un impact immatériel sur ses résultats de 2025.
Le PDG Joseph Dziedzic a déclaré que l'entreprise estime un impact de 1 à 5 millions de dollars sur le revenu d'exploitation ajusté pour l'année entière, ce qui tient compte des tarifs actuellement applicables et des tarifs supplémentaires annoncés le 2 avril après une pause de 90 jours. Cette estimation inclut à la fois les actions de mitigation mises en œuvre et celles prévues. Integer publiera ses résultats financiers du premier trimestre 2025 le 24 avril 2025.
Integer Holdings (NYSE: ITGR), ein Vertragsentwicklungs- und Fertigungsunternehmen, hat eine Erklärung zu den Auswirkungen der jüngsten Entwicklungen in der Handelspolitik und den Zöllen auf sein Geschäft abgegeben. Das Unternehmen erwartet, dass die angekündigten Zölle einen unbedeutenden Einfluss auf seine Ergebnisse für 2025 haben werden.
CEO Joseph Dziedzic erklärte, dass das Unternehmen einen Einfluss von 1 bis 5 Millionen Dollar auf das bereinigte Betriebsergebnis des gesamten Jahres schätzt, der die derzeit anwendbaren Zölle und die am 2. April nach einer 90-tägigen Pause angekündigten zusätzlichen Zölle berücksichtigt. Diese Schätzung umfasst sowohl umgesetzte als auch geplante Minderungsmaßnahmen. Integer wird seine Finanzzahlen für das 1. Quartal 2025 am 24. April 2025 veröffentlichen.
- Impact of tariffs deemed immaterial to 2025 results
- Mitigation actions already implemented and planned to address tariff impact
- Expected $1-5 million negative impact on 2025 adjusted operating income due to tariffs
~ Announced tariffs expected to have an immaterial impact on the Company’s 2025 results ~
PLANO, Texas, April 11, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading contract development and manufacturing organization, issued a statement on the impact of tariffs on its business given the recent extraordinary developments regarding trade policies.
“We continue to estimate an impact of
Integer plans to release financial and operational results for the first quarter 2025 on Thursday, April 24, 2025.
Learn more about Integer at www.integer.net.
About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at www.integer.net.
| Investor Relations: Kristen Stewart kristen.stewart@integer.net 551.337.3973 | Media Relations: Kelly Butler kelly.butler@integer.net 469.731.6617 |
Forward-Looking Statements
Some of the statements contained in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. The Company has based these forward-looking statements on its current expectations, and these statements are subject to known and unknown risks, uncertainties and assumptions. Forward-looking statements include, but are not limited to, statements regarding the expected impact of tariffs on 2025 adjusted operating income.
You can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “forecast,” “outlook,” “assume,” “potential” or “continue” or variations or the negative counterparts of these terms or other comparable terminology. These statements are only predictions and are no guarantee of future performance, and investors should not place undue reliance on forward-looking statements as predictive of future results. Actual events or results may differ materially from those stated or implied by these forward-looking statements. In evaluating these statements and the Company’s prospects, you should carefully consider the factors set forth below. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these cautionary factors. The Company disclaims any obligation to publicly update or revise the forward-looking statements made in this press release as a result of new information, future events or otherwise, except as required by law.
While it is not possible to create a comprehensive list of all factors that may cause actual results to differ from results expressed or implied by such forward-looking statements or that may affect the Company’s future results, some of these factors and other risks and uncertainties that arise from time to time are described in Item 1A “Risk Factors” of the Company’s Annual Report on Form 10-K and in its other periodic filings with the SEC and include the following:
- operational risks, such as the Company’s dependence upon a limited number of customers; pricing pressures and contractual pricing restraints the Company faces from customers; its reliance on third-party suppliers for raw materials, key products and subcomponents; interruptions in its manufacturing operations; its ability to attract, train and retain a sufficient number of qualified associates to maintain and grow its business; the potential for harm to its reputation and competitive advantage caused by quality problems related to its products; its dependence upon its information technology systems and its ability to prevent cyber-attacks and other failures; global climate change and the emphasis on environmental, social and governance matters by various stakeholders; its dependence upon its senior management team and key technical personnel; and consolidation in the healthcare industry resulting in greater competition;
- strategic risks, such as the intense competition the Company faces and its ability to successfully market its products; its ability to respond to changes in technology; its ability to develop new products and expand into new geographic and product markets; and its ability to successfully identify, make and integrate acquisitions to expand and develop its business in accordance with expectations;
- financial and indebtedness risks, such as the Company’s ability to accurately forecast future performance based on operating results that often fluctuate; its significant amount of outstanding indebtedness and its ability to remain in compliance with financial and other covenants under the credit agreement governing its senior secured credit facilities;
- legal and compliance risks, such as regulatory issues resulting from product complaints, recalls or regulatory audits; the potential of becoming subject to product liability or intellectual property claims; the Company’s ability to protect its intellectual property and proprietary rights; its ability to comply with customer-driven policies and third-party standards or certification requirements; its ability to obtain and/or retain necessary licenses from third parties for new technologies; its ability and the cost to comply with environmental regulations; legal and regulatory risks from its international operations; the fact that the healthcare industry is highly regulated and subject to various regulatory changes; and its business being indirectly subject to healthcare industry cost containment measures that could result in reduced sales of its products; and
- other risks and uncertainties that arise from time to time.
FAQ
What is the expected financial impact of tariffs on Integer Holdings (ITGR) in 2025?
When will the new tariffs affecting Integer Holdings (ITGR) take effect?
When will Integer Holdings (ITGR) release its Q1 2025 financial results?
How is Integer Holdings (ITGR) addressing the impact of new tariffs?
